These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men. Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687 [TBL] [Abstract][Full Text] [Related]
8. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691 [TBL] [Abstract][Full Text] [Related]
9. Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man. Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR Atherosclerosis; 1997 Nov; 135(1):83-91. PubMed ID: 9395276 [TBL] [Abstract][Full Text] [Related]
10. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects. Watts GF; Naoumova R; Cummings MH; Umpleby AM; Slavin BM; Sönksen PH; Thompson GR Metabolism; 1995 Aug; 44(8):1052-7. PubMed ID: 7637647 [TBL] [Abstract][Full Text] [Related]
11. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study. Christ ER; Cummings MH; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Naoumova RP; Boroujerdi MA; Sönksen PH; Russell-Jones DL J Clin Endocrinol Metab; 1999 Jan; 84(1):307-16. PubMed ID: 9920100 [TBL] [Abstract][Full Text] [Related]
12. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029 [TBL] [Abstract][Full Text] [Related]
13. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency. Cummings MH; Christ E; Umpleby AM; Albany E; Wierzbicki A; Lumb PJ; Sönksen PH; Russell-Jones DL J Clin Endocrinol Metab; 1997 Jun; 82(6):2010-3. PubMed ID: 9177423 [TBL] [Abstract][Full Text] [Related]
14. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss. Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434 [TBL] [Abstract][Full Text] [Related]
16. Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men. Watts GF; Riches FM; Kelly JM; Powell MA; Croft KD Clin Exp Pharmacol Physiol; 1997 Aug; 24(8):556-62. PubMed ID: 9269527 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase. Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098 [TBL] [Abstract][Full Text] [Related]
19. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. Watts GF; Riches FM; Humphries SE; Talmud PJ; van Bockxmeer FM J Lipid Res; 2000 Mar; 41(3):481-8. PubMed ID: 10706596 [TBL] [Abstract][Full Text] [Related]
20. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]